US Stock MarketDetailed Quotes

Neumora Therapeutics (NMRA)

Watchlist
  • 1.830
  • -0.110-5.67%
Close May 8 16:00 ET
  • 1.830
  • 0.0000.00%
Post 20:01 ET
339.07MMarket Cap-1.38P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Neumora Therapeutics (NMRA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-25.48%52.86M
-8.47%241.16M
-7.06%58.48M
-24.72%57.7M
-15.33%54.04M
18.08%70.94M
4.51%263.46M
-44.81%62.92M
34.79%76.65M
51.73%63.82M
Selling and administrative expenses
-24.06%14.27M
-3.91%60.09M
-18.81%13.81M
-23.95%12.18M
0.80%15.32M
31.21%18.79M
37.52%62.54M
51.39%17.01M
4.93%16.02M
63.50%15.19M
-General and administrative expense
-24.06%14.27M
-3.91%60.09M
-18.81%13.81M
-23.95%12.18M
0.80%15.32M
31.21%18.79M
37.52%62.54M
51.39%17.01M
4.93%16.02M
63.50%15.19M
Research and development costs
-25.99%38.6M
-9.89%181.07M
-2.71%44.67M
-24.92%45.52M
-20.37%38.72M
13.97%52.15M
-2.76%200.93M
-55.32%45.91M
45.74%60.63M
48.40%48.63M
Operating profit
25.48%-52.86M
8.47%-241.16M
7.06%-58.48M
24.72%-57.7M
15.33%-54.04M
-18.08%-70.94M
-4.51%-263.46M
44.81%-62.92M
-34.79%-76.65M
-51.73%-63.82M
Net non-operating interest income expense
-120.27%-623K
-74.29%5.13M
-117.15%-701K
-77.71%938K
-65.59%1.81M
-51.70%3.07M
20.00%19.93M
-27.59%4.09M
9.67%4.21M
48.15%5.27M
Non-operating interest income
-59.95%1.23M
-58.14%8.34M
-67.34%1.34M
-59.97%1.69M
-65.59%1.81M
-51.70%3.07M
20.00%19.93M
-27.59%4.09M
9.67%4.21M
48.15%5.27M
Non-operating interest expense
--1.85M
--3.22M
--2.04M
--747K
----
--0
----
----
--0
----
Other net income (expense)
336.00%59K
-883.33%-767K
-1,893.33%-269K
112.28%7K
-1,900.00%-480K
-108.33%-25K
54.12%-78K
114.42%15K
-5,600.00%-57K
38.46%-24K
Other non- operating income (expenses)
336.00%59K
-883.33%-767K
-1,893.33%-269K
112.28%7K
-1,900.00%-480K
-108.33%-25K
54.12%-78K
114.42%15K
-5,600.00%-57K
38.46%-24K
Income before tax
21.30%-53.43M
2.80%-236.8M
-1.07%-59.45M
21.71%-56.76M
10.02%-52.71M
-26.37%-67.89M
-3.37%-243.61M
45.77%-58.82M
-36.71%-72.49M
-51.97%-58.58M
Income tax
-71.43%30K
-26.97%130K
0
0
-80.00%25K
105K
-33.58%178K
0
53K
125K
Net income
21.38%-53.46M
2.81%-236.93M
-1.07%-59.45M
21.77%-56.76M
10.17%-52.73M
-26.57%-67.99M
-3.33%-243.79M
45.90%-58.82M
-36.81%-72.55M
-52.30%-58.7M
Net income continuous Operations
21.38%-53.46M
2.81%-236.93M
-1.07%-59.45M
21.77%-56.76M
10.17%-52.73M
-26.57%-67.99M
-3.33%-243.79M
45.90%-58.82M
-36.81%-72.55M
-52.30%-58.7M
Minority interest income
Net income attributable to the parent company
21.38%-53.46M
2.81%-236.93M
-1.07%-59.45M
21.77%-56.76M
10.17%-52.73M
-26.57%-67.99M
-3.33%-243.79M
45.90%-58.82M
-36.81%-72.55M
-52.30%-58.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
21.38%-53.46M
2.81%-236.93M
-1.07%-59.45M
21.77%-56.76M
10.17%-52.73M
-26.57%-67.99M
-3.33%-243.79M
45.90%-58.82M
-36.81%-72.55M
-52.30%-58.7M
Basic earnings per share
28.57%-0.3
5.23%-1.45
5.41%-0.35
22.22%-0.35
10.81%-0.33
-23.53%-0.42
57.85%-1.53
45.95%-0.37
60.53%-0.45
-45.87%-0.37
Diluted earnings per share
28.57%-0.3
5.23%-1.45
5.41%-0.35
22.22%-0.35
10.81%-0.33
-23.53%-0.42
57.85%-1.53
45.95%-0.37
60.53%-0.45
-45.87%-0.37
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -25.48%52.86M-8.47%241.16M-7.06%58.48M-24.72%57.7M-15.33%54.04M18.08%70.94M4.51%263.46M-44.81%62.92M34.79%76.65M51.73%63.82M
Selling and administrative expenses -24.06%14.27M-3.91%60.09M-18.81%13.81M-23.95%12.18M0.80%15.32M31.21%18.79M37.52%62.54M51.39%17.01M4.93%16.02M63.50%15.19M
-General and administrative expense -24.06%14.27M-3.91%60.09M-18.81%13.81M-23.95%12.18M0.80%15.32M31.21%18.79M37.52%62.54M51.39%17.01M4.93%16.02M63.50%15.19M
Research and development costs -25.99%38.6M-9.89%181.07M-2.71%44.67M-24.92%45.52M-20.37%38.72M13.97%52.15M-2.76%200.93M-55.32%45.91M45.74%60.63M48.40%48.63M
Operating profit 25.48%-52.86M8.47%-241.16M7.06%-58.48M24.72%-57.7M15.33%-54.04M-18.08%-70.94M-4.51%-263.46M44.81%-62.92M-34.79%-76.65M-51.73%-63.82M
Net non-operating interest income expense -120.27%-623K-74.29%5.13M-117.15%-701K-77.71%938K-65.59%1.81M-51.70%3.07M20.00%19.93M-27.59%4.09M9.67%4.21M48.15%5.27M
Non-operating interest income -59.95%1.23M-58.14%8.34M-67.34%1.34M-59.97%1.69M-65.59%1.81M-51.70%3.07M20.00%19.93M-27.59%4.09M9.67%4.21M48.15%5.27M
Non-operating interest expense --1.85M--3.22M--2.04M--747K------0----------0----
Other net income (expense) 336.00%59K-883.33%-767K-1,893.33%-269K112.28%7K-1,900.00%-480K-108.33%-25K54.12%-78K114.42%15K-5,600.00%-57K38.46%-24K
Other non- operating income (expenses) 336.00%59K-883.33%-767K-1,893.33%-269K112.28%7K-1,900.00%-480K-108.33%-25K54.12%-78K114.42%15K-5,600.00%-57K38.46%-24K
Income before tax 21.30%-53.43M2.80%-236.8M-1.07%-59.45M21.71%-56.76M10.02%-52.71M-26.37%-67.89M-3.37%-243.61M45.77%-58.82M-36.71%-72.49M-51.97%-58.58M
Income tax -71.43%30K-26.97%130K00-80.00%25K105K-33.58%178K053K125K
Net income 21.38%-53.46M2.81%-236.93M-1.07%-59.45M21.77%-56.76M10.17%-52.73M-26.57%-67.99M-3.33%-243.79M45.90%-58.82M-36.81%-72.55M-52.30%-58.7M
Net income continuous Operations 21.38%-53.46M2.81%-236.93M-1.07%-59.45M21.77%-56.76M10.17%-52.73M-26.57%-67.99M-3.33%-243.79M45.90%-58.82M-36.81%-72.55M-52.30%-58.7M
Minority interest income
Net income attributable to the parent company 21.38%-53.46M2.81%-236.93M-1.07%-59.45M21.77%-56.76M10.17%-52.73M-26.57%-67.99M-3.33%-243.79M45.90%-58.82M-36.81%-72.55M-52.30%-58.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 21.38%-53.46M2.81%-236.93M-1.07%-59.45M21.77%-56.76M10.17%-52.73M-26.57%-67.99M-3.33%-243.79M45.90%-58.82M-36.81%-72.55M-52.30%-58.7M
Basic earnings per share 28.57%-0.35.23%-1.455.41%-0.3522.22%-0.3510.81%-0.33-23.53%-0.4257.85%-1.5345.95%-0.3760.53%-0.45-45.87%-0.37
Diluted earnings per share 28.57%-0.35.23%-1.455.41%-0.3522.22%-0.3510.81%-0.33-23.53%-0.4257.85%-1.5345.95%-0.3760.53%-0.45-45.87%-0.37
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +20.00%
Sample Name
Sample Code
 +12.40%
Sample Name
Sample Code
 +11.01%
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+8.22%
5
United States Oil Fund LP
USO
+7.03%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.20%
Sample Name
Sample Code
 +18.16%
Sample Name
Sample Code
 +12.05%
4
KE Holdings
BEKE
+10.61%
5
ASE Technology
ASX
+8.36%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 7 Eastern Time, as the US-Iran negotiations entered a critical window amid external expectations and various parties' strategic maneu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -